“…A third form, common or covert toxocariasis (CT), was described in 1992 and 1993 for patients who were seropositive and presented with weakness, gastrointestinal disorders, and lethargy (77,78). Human toxocariasis is currently classified clinically into four types, including VLM, OT, CT, and NT (19,20,66). Regarding toxocariasis immunopathogenesis, TES antigens have been found to play a pivotal role in triggering granulomatous inflammation, a mani-festation of delayed-type hypersensitivity mediated by Th1 cells, as well as IgE, eosinophilia, and enhanced cytokine expression (e.g., interleukin-13 [IL-13], IL-5, and IL-4) characteristic of Th2-mediated responses (79).…”